Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.94 USD | -1.65% | -6.19% | -37.53% |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
Financials (USD)
Sales 2024 * | 101M | Sales 2025 * | 113M | Capitalization | 163M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | -12M | EV / Sales 2024 * | 1.61 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-16.8
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.15% |
Latest transcript on OptimizeRx Corporation
1 day | -1.65% | ||
1 week | -6.19% | ||
Current month | -26.42% | ||
1 month | -24.11% | ||
3 months | -39.96% | ||
6 months | +6.81% | ||
Current year | -37.53% |
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 9.09 | -2.47% | 213,898 |
24-04-19 | 9.32 | -0.32% | 298,861 |
24-04-18 | 9.35 | -1.89% | 153,709 |
24-04-17 | 9.53 | -4.32% | 137,451 |
24-04-16 | 9.96 | -3.49% | 202,777 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.53% | 165M | |
+15.80% | 381B | |
+18.62% | 239B | |
+14.96% | 144B | |
+18.22% | 99.5B | |
+14.47% | 79.04B | |
+30.81% | 51.42B | |
-3.17% | 34.84B | |
+15.04% | 31.04B | |
-10.85% | 22.34B |
- Stock Market
- Equities
- OPRX Stock